Is this message not displayed correctly?
Please click here for the online version.

December 2025
Photo Kai Uwe Bindseil

Dear Sir or Madam,

In our newsletter we have presented numerous internationally visible companies, from start-ups to global corporations, as well as research institutions and universities. All of them are significant partners of the Berlin-Brandenburg health cluster and thus part of a leading location for cutting-edge medicine, biotech, medical technology, and digital health. 

However, the region is also a magnet for international non-profit organizations (NPOs), which make a decisive contribution to innovation and global networking. Their work is more than just a supplement to the activities of companies and research institutions. They strengthen the capital region's position as a hub for global health and make many things possible in the first place. Today, I would like to introduce you to some of the organizations with which the Health Industry Cluster enjoys working successfully: 

Charité Foundation – Excellence and local support 

The Charité Foundation is a prime example of the impact of NPOs in Berlin. It supports Charité – Universitätsmedizin Berlin and its partners through programs for innovation promotion, science, and open life science. In doing so, it contributes to establishing Berlin as a leading international location for life sciences. The foundation initiates collaborations, promotes talent, and enables projects that shorten the path from research to application—a key lever for the region's competitiveness. 

WHO Hub – Global Health from Berlin 

With the WHO Hub for Pandemic and Epidemic Intelligence, Berlin has become a center for international health surveillance. The hub develops innovative approaches for the early detection of health threats, promotes the exchange of data and analyses, and supports over 150 countries in strengthening their health systems. This means that Berlin is directly involved in the global architecture for pandemic prevention – a locational advantage that extends far beyond the region. 

UNFPA – Focus on women's and family health 

Since 2025, the United Nations Population Fund (UNFPA) has operated an office in Berlin that is committed to promoting women's health, especially sexual and reproductive health. With initiatives such as the WomenX Collective, UNFPA is providing new impetus for women's health and promoting partnerships between science, politics, and business. Berlin offers an ideal ecosystem for this – and is thus becoming the starting point for global programs that will benefit millions of women and girls. 

Bill & Melinda Gates Foundation – Network diplomacy for global health 

The Gates Foundation opened its European office in Berlin in 2018 and uses the capital region as a platform for strategic partnerships in research, development, and politics. With projects to combat infectious diseases, strengthen health systems, and promote digital innovation, the foundation is helping to advance global health goals – and connecting Berlin-based actors with international initiatives. 

Virchow Foundation – Focus on global health 

The Virchow Foundation for Global Health was founded in Berlin in 2021 to raise awareness of global health issues and promote the implementation of the UN Sustainable Development Goals (SDGs). It understands health as a holistic concept that incorporates medical, social, political, and economic factors. Centerpiece of the foundation is the annual Virchow Prize for Global Health, an internationally renowned award that recognizes outstanding lifetime achievements and innovations that contribute significantly to improving health worldwide. 

Foundations and non-profit organizations – “enablers” for life sciences and health  

These organizations are more than partners—they are drivers of innovation, internationalization, and social responsibility. They bring expertise, networks, and resources to the region and make Berlin-Brandenburg a hub for the healthcare industry of tomorrow.  

They are just a few examples of the wide range of foundations and non-profit initiatives committed to health in Berlin-Brandenburg. They all make an indispensable contribution – whether by promoting research, networking global players, or implementing innovative projects. Especially now, in the Christmas season, when we pause and show gratitude, it is a good moment to appreciate the work and successes of these foundations – and many others that are committed to specific indications and medical topics. Let us work together to ensure that they continue to receive the support and visibility they deserve in the future. 


Your
Dr. Kai Bindseil
Berlin Partner for Business and Technology



Focus Topics

Banner Focus Topics

The Health & Biotech Start-up Ecosystem in Berlin-Brandenburg – Starting a Business with Support and Perspective

It’s not difficult to come across start-ups and young companies in the capital region. Berlin-Brandenburg boasts a diverse and steadily growing start-up ecosystem. And financing options are just as diverse as this ecosystem, encompassing various government funding models, private investors and venture capital firms. The region’s biotech and health sector in particular has seen many very successful financing rounds in recent years. We give an overview of the capital region’s start-up ecosystem in these segments.

Noah Labs – Detecting Heart Problems through the Voice

In Germany, inpatient hospital stays are often due to heart failure. Berlin-based start-up Noah Labs wants to change this and spare patients with chronic heart failure hospital admittance. Their method of choice is the development of AI-supported software that analyzes voice changes. Noah Labs is already enjoying market success with another software that telemonitors patients with heart failure. We present the company and its journey.

Global and innovative – isotope technology components for precision oncology

Eckert & Ziegler Group is one of the world's largest suppliers of isotope technology components for medical, scientific and industrial applications. Since its foundation in the 1990s, all of Eckert & Ziegler’s company functions have been headquartered in Berlin-Buch, and the group was able to continuously expand its global activities with further national and international production, service and distribution sites. We spoke with Dr. Harald Hasselmann, Chairman of the Executive Board, about regional and global strategies for success and innovation.

Stiftung Charité – providing impetus, promoting life sciences in Berlin, shaping the future

Since its establishment in 2005, Stiftung Charité has been one of the most important institutions to support innovative minds and projects in Berlin’s life sciences sector. As a private, non-profit organization, the foundation promotes institutions affiliated with Charité – Universitätsmedizin Berlin and other life science partner institutions. This portrait provides an overview of the foundation's history and work.



Meet us at ...

Banner Meet us at

ANT Neuromeeting 2026 

15-17 January 2026 | Berlin, Germany 

Read more

RegMed Forum 2026: Clinical translation of advanced therapeutic approaches 

19 February 2026 | Berlin, Germany

Read more

DigitalHealthCapital@DMEA2026

20-24 April 2026 | Berlin, Germany 

Read more

SAVE THE DATE: bio:cap International 
Life Science and AI Investival 

9-11 June 2026 | Berlin, Germany 

Read more

The tip from our relocation experts 

Looking for a cooperation partner in Germany’s capital region?

Discover Health Made in Germany, the national platform for connecting with life science and biotech partners across the country.

 

Gain free access to over 3,500 company profiles in the German healthcare market. Each profile provides detailed insights into company activities, product and service portfolios, financial data and direct contact information, making it easy to start meaningful partnerships. 

For a quick Berlin-focused search, simply enter your desired sector, location and additional keywords to instantly generate a list of potential partner companies in the capital region. 

👉 Explore now  

We are happy to assist you making your company a part of our thriving ecosystem. Contact us! 

Susann Kaffenberger   
Manager Biotech | Pharma   
Berlin Partner for Business and Technology 

CONTACT US! 

For more events in the life science region Berlin-Brandenburg click here.



Business News

Banner Business News

4TEEN4 Extends Series C Financing Round to

€55 Million

4TEEN4 Pharmaceuticals GmbH announced an extension of its Series C financing to €55 million ($64 million), with participation from existing and new investors. The funds will support the development of procizumab for patients with shock caused primarily by cardiogenic events, expand the PROCARD 2a study across Europe, and prepare for U.S. market entry ahead of the pivotal trial.


Read more

Berlin's Voize Raises $50M for Nursing AI

Berlin-based Voize closed a $50 million Series A round led by Balderton Capital, with support from HV Capital, Redalpine, and Y Combinator. The investment will drive Voize’s European expansion and U.S. launch as the company tackles one of healthcare’s biggest challenges: giving nurses more time for patient care.

Read more

Financing Success: €20 Million for Captain T Cell 

Captain T Cell secured €20 million in a major financing round to advance next-generation TCR-T therapies. The funding will enable the first Phase I clinical trial for lead program CTC127 and accelerate development of its allogeneic “off-the-shelf” platform toward clinical readiness.

Read more

Knauer Acquires Labomatic AG and Strengthens Its Leading Position in Preparative HPLC


Read more

Digital Heart Summit 2025: AI and Patient Empowerment Take Center Stage in Cardiology’s Future


Read more

IBA Acquires PhantomX GmbH


Read more

IAVI, Minapharm, and ProBioGen Announce Memorandum of Understanding to Progress Clinical Development, Manufacturing, Commercialization, and Access to Vaccines and Antibodies in Africa


Read more



Science and Technology News

Banner Science and Technology News

Why the "gut brain" Plays a Central Role in Allergies

An international research team led by scientists from Charité – Universitätsmedizin Berlin and Bern has identified a previously unknown function of the intestinal nervous system. As the team now reports in the journal Nature Immunology*, the intestinal nervous system plays a key role in regulating both the composition and stability of the intestinal barrier. Disruption of this protective mechanism can lead to the development of allergies. 

Using Deep Learning for Precision Cancer Therapy

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in “Nature Communications,” the tool, called Flexynesis, uses deep neural networks and evaluates multi modal data.

Read more

New Insights into the Role of Stellate Cells and Blood Vessels in the Aging Pancreas

As age increases, the pancreas changes, which increases the risk of metabolic diseases such as type 2 diabetes, digestive disorders, and also cancer. Researchers at the German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE) have now been able to show in an animal model that stellate cells, in interaction with blood vessels, play a key role in age-related changes in the pancreas. They published their results in the journal Redox Biology.

Read more

New Findings About the Aging Brain


Read more

Sugar Fingerprints to Fight Fungal Infections


Read more

Gene Editing to Treat Inherited Kidney Disease


Read more

Development of the European Cancer Information Portal Launched


Read more

Why APOE4 Raises Alzheimer’s Risk


Read more

Time-Restricted Eating Without Calorie Reduction Does Not Improve Metabolic Health but Shifts the Body's Internal Clocks


Read more

Einstein Research Unit for Global Health Technologies Launched


Read more



Technology and Cooperation Offers

Banner Technology and Cooperation Offers

Sleeping Beauty transposase variants with increased safety due to reduced half-life 


Read more

Improved Sleeping Beauty Transposon System for gene therapy: SB100X/pT4 


Read more
For more news from the cluster healthcare industries click here.

LinkedIn Firmenname
EDITOR | IMPRINT

This newsletter is operated by the cluster healthcare industries
Berlin-Brandenburg HealthCapital.


Berlin Partner for Business and Technology
Fasanenstrasse 85 | 10623 Berlin | Germany
Phone: +49 30 46302-463
Email: healthcapital(at)berlin-partner.de

Commercial Registry Entry
Entered in the commercial registry of the Charlottenburg District Court,
Registration number: HRB 13072 B 
VAT ID: DE 136629780

CEO: Dr. Stefan Franzke

Chairman of the Supervisory Board: Carsten Jung


Editorial: In cooperation with dpa-Custom Content.

Responsible body in terms of German Press Law
Carolin Meltendorf, Press Spokeswoman Berlin Partner for Business and Technology


© 2025 Berlin Partner for Business and Technology
 
The newsletter of the Cluster healthcare industries Berlin-Brandenburg is a project of Berlin Partner for Business and Technology.

 
 
Logo THE GERMAN CAPITAL REGION
 
You have been forwarded this newsletter and would like to subscribe?
Please click here.



You want to unsubscribe from the newsletter (to: unknown@noemail.com)? Please click here.